Chronic News and Research

RSS

Baxter International lauds new Medicare education benefit for chronic kidney disease patients

Baxter International Inc. commends the Centers for Medicare and Medicaid Services (CMS) on announcing implementation plans for a new Medicare benefit that will provide Stage 4 chronic kidney disease patients with coverage for up to six sessions explaining their treatment options, such as transplantation, home peritoneal dialysis (PD), home hemodialysis (HHD) or clinic-based hemodialysis (HD).

From Baxter International Inc. 10 Nov 2009

Exposure to common infections may increase stroke risk

Cumulative exposure to five common infection-causing pathogens may be associated with an increased risk of stroke, according to a report posted online today that will appear in the January 2010 print issue of Archives of Neurology, one of the JAMA/Archives journals.

10 Nov 2009

Consortium of researchers produce a special issue that examines healthcare disparities affecting minorities

The Latino population is the nation's largest minority group at an estimated 47 million in 2008 and is predicted to make up 30% of the US population by 2050. At the same time, chronic diseases among Latinos are on the rise and require long-range strategies to prevent and clinically manage. Understanding the healthcare of this fastest growing population is critical to the healthcare debate and reform initiatives.

10 Nov 2009

Treatment of allergic rhinitis can improve nasal and ocular symptoms

The treatment of allergic rhinitis is shown to improve co-existing conditions including conjunctivitis, asthma, sinusitis, otitis media with effusion (fluid in the middle ear) and sleep disorders according to an international expert at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.

10 Nov 2009

Cannabinoid medicine: Challenges for health care providers and its potential benefits for patients

Groundbreaking articles in current issues of Journal of Opioid Management, for the first time explore, in depth, the emergence of cannabinoid medicine, its challenges for health care providers and its potential benefits for patients.

10 Nov 2009

Prostatitis is a psychoneuromuscular condition: Study

In the November 2009 issue of the Journal of Urology, Stanford Medical School researcher Dr. Rodney Anderson and researchers at the National Center for Pelvic Pain Research, in a new study, demonstrated a high correlation between the location of painful trigger points inside the pelvic floor muscles of men with chronic prostatitis and the location in the body where they routinely complain of pain.

10 Nov 2009

"Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads" report from MarketResearch.com

MarketResearch.com has announced the addition of Kalorama Information's new report "Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads," to their collection of In Vitro Diagnostics market reports.

10 Nov 2009

Astellas receives exclusive rights to develop and commercialize linaclotide compound in Asia

Ironwood Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that they have entered into an agreement providing Astellas exclusive rights to develop and commercialize the investigational compound linaclotide in Japan, Indonesia, Korea, the Philippines, Taiwan, and Thailand.

10 Nov 2009

Dark side of compulsive eating

Researchers from Boston University School of Medicine (BUSM) have shown that intermittent access to foods rich in fat and sugar induces changes in the brain which are comparable to those observed in drug dependence. The findings, reported in the journal Proceedings of the National Academy of Sciences, may explain how abstinence from these foods contributes to relapse eating among dieters as well as related eating disorders.

10 Nov 2009

MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus

MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has acquired a portfolio of compounds for the potential treatment of respiratory syncytial virus (RSV) from ViroPharma Incorporated (Exton, PA). The lead investigational compound in the portfolio is an inhalable small molecule fusion inhibitor, now called MDT-637.

10 Nov 2009

AAPA commends the passage of Affordable Health Care for America Act

The American Academy of Physician Assistants (AAPA), representing more than 75,000 clinically practicing physician assistants (PAs) practicing in the United States, applauds the U.S. House of Representatives for passing Saturday its health care reform bill, H.R. 3962, the Affordable Health Care for America Act.

10 Nov 2009

Harvest Technologies completes patient enrollment in its non-reconstructable Critical Limb Ischemia trial

Harvest Technologies Corp. announced today that the company sponsored 48-patient IDE clinical trial conducted at seven sites in the U.S. and one site in India using the company's Bone Marrow Aspiration Concentrate (BMAC) System to treat patients with non-reconstructable Critical Limb Ischemia (CLI) has completed enrollment. Mark D. Iafrati, M.D. Chief of Vascular Surgery at Tufts Medical Center in Boston, directed the study.

10 Nov 2009

FDA accepts ChemGenex Pharmaceuticals' NDA for Omapro

ChemGenex Pharmaceuticals Limited announced today that the U.S. Food & Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for Omapro™ (omacetaxine mepesuccinate) for the treatment of patients with chronic myeloid leukemia (CML) who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation.

10 Nov 2009

Military personnel with back pain unlikely to return to duty after treatment

Military personnel evacuated out of Iraq and Afghanistan because of back pain are unlikely to return to the line of duty regardless of the treatment they receive, according to research led by a Johns Hopkins pain management specialist.

9 Nov 2009

TRICARE South Region beneficiaries urged to get H1N1 influenza vaccinations

Humana Military Healthcare Services, a wholly-owned subsidiary of Humana Inc. (NYSE: HUM), encourages TRICARE South Region beneficiaries to get their H1N1 influenza vaccinations in an effort to reduce the spread of the virus. Anticipating a greater need for the shots, the Department of Defense (DoD) is encouraging all military personnel to obtain the vaccines.

9 Nov 2009

FDA grants marketing approval for Wright Medical Group's CONSERVE Plus Total Hip Resurfacing System

Wright Medical Group, Inc., a global orthopaedic medical device company, announced today that the United States Food and Drug Administration (FDA) has given approval to the Company to market its original CONSERVE® Plus Total Hip Resurfacing System. Now available in the United States, this innovative total surface arthroplasty system provides surgeons and their patients a bone-conserving alternative to traditional total hip replacement.

9 Nov 2009

Covidien contraindicates use of its Optimark gadoversetamide injection

Covidien, a leading global provider of healthcare products, today announced that it will voluntarily contraindicate the use of its Optimark™ gadoversetamide injection, a gadolinium-based contrast agent (GBCA), in magnetic resonance imaging (MRI) procedures involving patients with severe renal impairment.

9 Nov 2009

Progenics Pharmaceuticals reports financial results for the third quarter of 2009

Progenics Pharmaceuticals, Inc. today announced its results of operations for the third quarter and nine months ended September 30, 2009.

9 Nov 2009

Public health experts urge Congress not to overlook the needs of Americans with "morbid obesity"

As the House of Representatives and the Senate debate companion bills to make health care more affordable and accessible, a coalition of obesity and public health experts today urged Congress not to overlook the needs of the more than 15 million Americans who suffer from severe obesity and are at the greatest risk for chronic disease and death.

9 Nov 2009

GTx reports financial results for the third quarter of 2009

GTx, Inc. today reported financial results for the third quarter of 2009. The net loss for the third quarter and nine months ended September 30, 2009 was $12.8 million and $35.4 million, respectively, compared with a net loss of $11.9 million and $37.9 million for the same periods in 2008. At September 30, 2009 GTx had cash, cash equivalents and short-term investments of $55.5 million.

9 Nov 2009

Chronic News and Research

Baxter International lauds new Medicare education benefit for chronic kidney disease patients

Exposure to common infections may increase stroke risk

Consortium of researchers produce a special issue that examines healthcare disparities affecting minorities

Treatment of allergic rhinitis can improve nasal and ocular symptoms

Cannabinoid medicine: Challenges for health care providers and its potential benefits for patients

Prostatitis is a psychoneuromuscular condition: Study

"Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads" report from MarketResearch.com

Astellas receives exclusive rights to develop and commercialize linaclotide compound in Asia

Dark side of compulsive eating

MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus

AAPA commends the passage of Affordable Health Care for America Act

Harvest Technologies completes patient enrollment in its non-reconstructable Critical Limb Ischemia trial

FDA accepts ChemGenex Pharmaceuticals' NDA for Omapro

Military personnel with back pain unlikely to return to duty after treatment

TRICARE South Region beneficiaries urged to get H1N1 influenza vaccinations

FDA grants marketing approval for Wright Medical Group's CONSERVE Plus Total Hip Resurfacing System

Covidien contraindicates use of its Optimark gadoversetamide injection

Progenics Pharmaceuticals reports financial results for the third quarter of 2009

Public health experts urge Congress not to overlook the needs of Americans with "morbid obesity"

GTx reports financial results for the third quarter of 2009

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News